National Advisory Committee on Immunization prioritizes four groups to first receive Covid-19 vaccine but does not provide the distribution framework whilst the National Academies of Sciences, Engineering, and Medicine does so with caveats.

Dr. Barry Dworkin

Medical Mythbusting Commentary for November 6, 2020

National Advisory Committee on Immunization prioritizes four groups to first receive Covid-19 vaccine but does not provide the distribution framework whilst the National Academies of Sciences, Engineering, and Medicine does so with caveats. Play Now | Play in Popup | Download

Source:
New recommendations outline who in Canada could get a COVID-19 vaccine first

National Academies Release Framework for Equitable Allocation of a COVID-19 Vaccine for Adoption by HHS, State, Tribal, Local, and Territorial Authorities


Related posts:

  1. Study bias against methadone distribution clinics blinds them to the deficiencies of mental health cares services in Ontario
  2. Vaccine trial suspension is an expected response after reports of a single adverse event. It shows that proper protocols are being followed to determine if it is related to the vaccine. Phase 3 trials are designed to determine how larger and more diverse population groups respond.
  3. The vaccine development process is still beholden to clinical trial realities and barriers that are beyond our control. Predicting when we will have a Covid-19 vaccine is a mug’s game. Could be tomorrow, could be next year.
  4. If you are the WHO boss suggesting that a COVID vaccine MAY be available by the end of the year, provide the evidence to justify the hope, else be prepared for another journey into the nadir of credibility and subsequent irrelevance if you are wrong.
Bitnami